Spyre Therapeutics, Inc.

WELLINGTON MANAGEMENT GROUP LLP SYRE

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/14/2023

Shares

8,819,168

Value ($000)

3,973

Weight

0.0%

2023 Q2 - 2023 Q2 (1 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/14/2023	3,973	0.0%	8,819,168	6/30/2023